Jane M. Liebschutz, MD, MPH
- M-PI, University of Pittsburgh
- Chief, Division of General Internal Medicine
- Professor of Medicine with Tenure
- UPMC Endowed Chair of Translational Medicine and Research
- Director, Center for Research on Health Care
Dr. Liebschutz serves as M-PI of the NIDA CTN Appalachian Node with Dr. Erin Winstanley of West Virginia University. In this role, she directs research activities based at the University of Pittsburgh, associated UPMC Health System, and research sites in the surrounding region. She is co-leading CTN-101, Subthreshold Opioid Use Disorder Prevention (STOP) Trial, an NIH HEAL Initiative trial. She serves on the CTN Steering Committee and the CTN Methadone Task Force.
Dr. Liebschutz’s research is focused on developing interventions to combat the current crisis in opioid use disorders. More broadly her research focuses on substance use, violence, and mental health within the practice of general medical care. Earlier in her career, she studied violence and its health impacts—knowledge that she uses in her current work on substance abuse disorders. Dr. Liebschutz has conducted numerous observational and intervention studies, including research on opioid prescribing for chronic pain in primary care, HIV settings and among patients on hemodialysis. She has also directed randomized trials to study the treatment of opioid and injection drug use disorders in hospitalized patients.